Showing results (621-630 of 1,675) with videos related to

Sort By:
Pageof 168
The Journal of Sexual Medicine|June 8, 2012
Is a treatment delay in radical prostatectomy safe in individuals with low-risk prostate cancer?Maxine Sun, Firas Abdollah, Jens Hansen, et al.
European Urology|December 17, 2011
A non-cancer-related survival benefit is associated with partial nephrectomyMaxine Sun, Quoc-Dien Trinh, Marco Bianchi, et al.
International Journal of Radiation Oncology, Biology, Physics|December 17, 2011
High-dose adjuvant radiotherapy after radical prostatectomy with or without androgen deprivation therapyPiet Ost, Cesare Cozzarini, Gert De Meerleer, et al.
The Journal of Urology|December 20, 2011
Hospital volume is a determinant of postoperative complications, blood transfusion and length of stay after radical or partial nephrectomyMaxine Sun, Marco Bianchi, Quoc-Dien Trinh, et al.
BJU International|May 9, 2013
An analysis of patients with T2 renal cell carcinoma (RCC) according to tumour size: a population-based analysisMarco Bianchi, Andreas Becker, Quoc-Dien Trinh, et al.
European Urology|September 14, 2014
Identifying optimal candidates for local treatment of the primary tumor among patients diagnosed with metastatic prostate cancer: a SEER-based studyNicola Fossati, Quoc-Dien Trinh, Jesse Sammon, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|May 6, 2008
Hypofractionated adjuvant radiotherapy with helical tomotherapy after radical prostatectomy: planning data and toxicity results of a Phase I-II studyCesare Cozzarini, Claudio Fiorino, Nadia Di Muzio, et al.
BJU International|January 29, 2014
Survival benefit of definitive therapy in patients with clinically advanced prostate cancer: estimations of the number needed to treat based on competing-risks analysisGiorgio Gandaglia, Maxine Sun, Quoc-Dien Trinh, et al.
BJU International|March 20, 2015
Impact of stage migration and practice changes on high-risk prostate cancer: results from patients treated with radical prostatectomy over the last two decadesNicola Fossati, Niccolò M Passoni, Marco Moschini, et al.
Urologia|December 23, 2015
Pelvic lymph node dissection in prostate cancer: indications, extent and tailored approachesLorenzo Bianchi, Giorgio Gandaglia, Nicola Fossati, et al.
Pageof 168